Multiple Sclerosis is a weakening neurological disease that is thought to be initiated by destruction of the myelin sheaths (fatty protective insulation) around axons of the brain and spinal cord. Loss of myelin affects the capability of these tissues to conduct signals and the inflammatory procedure can lead to scarring resulting in a wide range of symptoms. This myelin damage seems to be identified fundamentally to an auto-immune dysfunction, but there also appears to be environmental and genetic factors included. There is no known cure for the physical and cognitive defects connected with chronic Multiple Sclerosis. Numerous investigators are taking a look at utilizing the regenerative properties of cell therapy to alleviate the effect of Multiple Sclerosis on the nervous system.
Multiple Sclerosis and Regenerative Medicine Institute of Nevada
RMIN has developed a particular SVF deployment convention that endeavors to use the immuno-regulatory and anti-inflammatory properties of SVF(rich in mesenchymal stem cells and growth factors). Extraordinary measures are taken to optimize transport of the SVF over the blood-brain barrier to improve central nervous system uptake. This is all done as an outpatient around the time of SVF collecting and obtainment. The whole cell surgical procedure takes roughly three hours.
Multiple Sclerosis Call to Action
In caring for our Multiple Sclerosis patients at the Regenerative Medicine Institute of Nevada, we take pride in using the best medical protocols and current technology to help our patients become their best. Contact us and we will answer the inquiries and concerns you might have about Regenerative Medicine Institute of Nevada conventions for Multiple Sclerosis.